A detailed history of Central Pacific Bank Trust Division transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 53,030 shares of TEVA stock, worth $888,782. This represents 0.11% of its overall portfolio holdings.

Number of Shares
53,030
Previous 42,427 24.99%
Holding current value
$888,782
Previous $935 Million 12.84%
% of portfolio
0.11%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 03, 2025

BUY
$14.67 - $22.01 $155,546 - $233,372
10,603 Added 24.99%
53,030 $815 Million
Q4 2024

Jan 03, 2025

BUY
$16.43 - $22.77 $697,075 - $966,062
42,427 New
42,427 $935 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.